GSG2 | Germ cell associated 2 (haspin) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GSK3B | Glycogen synthase kinase 3 beta | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GUCY2F | Guanylate cyclase 2F, retinal | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Not detected |
HCK | HCK proto-oncogene, Src family tyrosine kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HIPK1 | Homeodomain interacting protein kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK3 | Homeodomain interacting protein kinase 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK4 | Homeodomain interacting protein kinase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
HUNK | Hormonally up-regulated Neu-associated kinase | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ICK | Intestinal cell (MAK-like) kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKE | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
IRAK2 | Interleukin-1 receptor-associated kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
IRAK3 | Interleukin-1 receptor-associated kinase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRAK4 | Interleukin-1 receptor-associated kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
JAK1 | Janus kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
KALRN | Kalirin, RhoGEF kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR2 | Kinase suppressor of ras 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LATS1 | Large tumor suppressor kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LATS2 | Large tumor suppressor kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
LIMK2 | LIM domain kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LMTK2 | Lemur tyrosine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LMTK3 | Lemur tyrosine kinase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
LRRK1 | Leucine-rich repeat kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
LRRK2 | Leucine-rich repeat kinase 2 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LTK | Leukocyte receptor tyrosine kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MAK | Male germ cell-associated kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K3 | Mitogen-activated protein kinase kinase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K4 | Mitogen-activated protein kinase kinase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K5 | Mitogen-activated protein kinase kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K6 | Mitogen-activated protein kinase kinase 6 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K7 | Mitogen-activated protein kinase kinase 7 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAP3K1 | Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |